Top ten Android browser for 2016

Web browsers are one of the most important apps on any device. Having the right features and performance while browsing the web can literally change your entire experience. Finding the right one can be difficult because there are so many options and the face of the web is changing all the time. Let’s take a look at the best Android browsers of 2016 (so far)!

Dolphin Browser: Free
Dolphin Browser has seen a lot of success on Android and it’s easy to see why. It has always been a fan favorite and it has a competent set of features to match, including theming, flash support, ad-block, incognito mode, and some tertiary features like gesture controls. There is also add-on support if you need that. A lot of people swear by Dolphin Browser and it covers all the bases in order to be considered one of the best out there.

Firefox: Free
Firefox browser has come a long way since it was first introduced on mobile. It was quickly become one of the must-have browsers and has an impressive set of features to back it up. Some of the features include desktop syncing (bookmarks, history, etc), privacy features, easy-to-use bookmarks, quick sharing, Chromecast support, and you’ll have access to some add-ons to improve the browsing experience. It’s a powerful Android web browser and it’s completely free to use. If you want to see the newest features sooner, you can also check out the beta version of Firefox.

Flynx: Free
Flynx by InfiKen Labs has come a long way since its inception and has earned itself a spot on the list. This unique browser works in a floating window as opposed to a full screen mode which allows for quick web browsing without really leaving the app that you’re using. When you click links, they open a little bubble on the side of the screen and the page will load in the background until you decide to click the bubble to read it yourself. It also comes with a few other features, such as night mode. If you’re looking for another surrogate, Link Bubble is another browser that uses this style that’s really good.

Ghostery Browser: Free
Ghostery is perhaps best known for its browser extensions for Firefox and Google Chrome. The extension allows you to block website trackers and it also lets you see what trackers are being used. Ghostery Browser puts all of this purpose into a browser so you can get the same thing on mobile. Indubitably, the browser itself is a little subdued in terms of other features but it gets the job done and has at least the basic stuff like bookmarks. It’s a great option for those who care about their privacy.

Google Chrome: Free
Of course we give the obligatory nod to the most popular browser on Android and that’s Chrome browser. Many people have this pre-installed on their devices and opt to just keep using it which is a perfectly reasonable thing to do. It features desktop syncing with Google Chrome on desktop along with the latest Material Design, unlimited browsing tabs, deeper integration with Android, and plenty of other features for both basic browsing and power users. You can even get in on the beta version and dev channel version if you want to see what’s coming up sooner on Chrome.

Mercury Browser: Free
Mercury Browser by iLegendsoft Inc started out as a popular browser on iOS before coming to Android. This browser focuses a little more on privacy and security than most and includes a passcode lock as well as private mode (incognito mode) for private browsing. It also has flash support, ad-block support, gesture controls, theming, and you can choose which search engine you want to use. It has a long list of features and provides a very strong browsing experience.

Opera Browser: Free
Opera Browser has been one of the mainstays when it comes to Android web browsers. It has been frequently updated over the years to bring all kinds of new features. Some of them include a Speed Dial where you can save your favorite sites quickly, some data saving features, and a decent interface that works well on phones as well as tablets. Their Opera Mini Browser expands on the data savings features while still providing a decent web browsing experience if you want to go that route. On top of that, you can also try out the latest features that Opera is testing by using Opera Browser beta and, of course, Opera Mini beta. All four of them are extremely capable browsers.

Puffin Browser: Free with in-app purchases
Puffin Browser by CloudMosa Inc is definitely the wild card on this list. It works well enough in most instances and the app is accompanied by some strange, very unique features. They include a virtual mouse pad, a gaming mode, and more. It also comes with some normal features like theming, an incognito mode, and some data saving features. It is one of the few browsers left that comes with full Adobe Flash support but it only gives that support for up to 12 hours per day. Otherwise, it’s quick, it’s fun, and it’s a little different.

UC Browser: Free
Last on our list is the venerable UC Browser. This is one of the most popular browsers on the Google Play Store and one of the few that targets people outside of the United States. It comes with a bunch of features, including ad-block, data compression, night mode, and gesture control. There are also some unique features, like Facebook mode which magically increases browsing speeds while on Facebook. It’s completely free to use and has also got a 4.5 rating on the Google Play Store with over seven million reviews to date. That’s impressive!

5 iPhone tricks you need to know By Yoni Heisler

With the recent release of iOS 9, we’ve already covered an incredible number of new iOS OS features that both iPhone and iPad users alike can take advantage of. Lost in the shuffle though, are some pretty awesome and helpful iOS tips and tricks that, while perhaps not new to iOS 9, are still incredibly useful and not all that well-known.
Listed below are a collection of five (5) awesome iOS tips that will work swimmingly with any iPhone model you’re likely using. So even if you haven’t managed to get your hands on the iPhone 6s just yet, not to fear, you can still make use of these cool features.

1. Autofill Credit Card information

Entering in your credit card information online can be a laborious process. iOS, however, simplifies everything by allowing users to store their credit card information by either a) entering it in manually or b) taking a photo of it. To do so, go to Settings > Safari > AutoFill > Saved Credit Cards > Add Credit Card.

Once you have a card stored, you can easily autofill online credit card forms (along with name and address information if you so choose) by simply tapping the “AutoFill Credit Card” option when a website issues a prompt for your credit card number.

2. Search for a word on a webpage

This is a trick that you’ll probably make frequent use of once you commit it to memory. Though it’s not readily apparent, mobile Safari makes searching for a particular word or phrase on a webpage extremely easy. To initiate a search, simply tap on the URL bar of whatever current page you’re on and begin typing the phrase you’re looking for.

Following that, a list of suggested Google Search phrases will appear. But if you move to the bottom of the screen, you’ll notice a section called “On This Page.”

Tap the entry directly below ‘On This Page’ and you’ll be now able to quickly cycle through all instances of that phrase on the webpage in question. Again, this isn’t a widely known feature, but it’s tremendously helpful.

3. Set up automatic alerts for important email replies

If you’re anxiously awaiting for a reply to an important email you sent out, or even if you simply want to be notified anytime an important multi-person email thread is updated, iOS makes it easy to set up and receive an alert every time a response comes in.

To set up an automatic alert, simply open up the Mail app and perform a left swipe on any specific message from within your inbox. From there, tap on the ellipses icon.

Next, select ‘Notify Me’ whereupon you’ll be asked to confirm the selection one more time.

4 . Save storage by automatically deleting messages after 30 days

The Messages app can be a sneaky storage hog, especially for users who like sending or receiving a lot of photos and videos. To keep the storage footprint of your Messages app to a minimum, you can have iOS automatically delete messages either after 30 days or after a year. Now don’t worry, iOS by default won’t delete any of your texts on its own, but if you’re interested in adding a bit of Snapchat-like mojo to your iOS Messages experience, you can do so by going to Settings > Messages > Keep Messages.

5. Easily use a timer with the Camera app

Apple over the years has added a number of features to its Camera app that were previously available exclusively via third-party apps. One such feature is the ability to take a timed photo.

To get started, open up the Camera app and you’ll notice some semblance of a clock icon located at the top. If you tap it once, you’ll be presented with the option to set either a three (3) second or ten (10) second timer. Once you have a time increment selected, the timer will begin counting down once you press the shutter button.

Note that when you have the timer enabled, the camera will automatically enable burst mode, meaning that it will take ten (10) photos in quick succession to ensure that you get the shot you’re looking for.

Seven Ways To Get The Best Out Of Your EMPLOYEES –

Every entrepreneur should know that the best way to sustain his/her business is to hire competent employees that can be motivated to significantly contribute to the attainment of the overall objectives of the enterprise.

Consider these seven steps to getting the best out of your employees:

1. Sell them the organizational vision to run with: Making your employees understand the organizational vision enables them to key into it so that they can effectively perform their task to contribute to the attainment of the vision. But doing this, you must take time to remind them of what the end result will be and inspire them despite challenges to focus on the vision.

2. Make public your high expectation of them: Quite often people tend to rise to your expectation of them if you inspire them by expressing your belief in their ability to deliver on their task even when they make mistakes. That way they will be spurred to meet your expectation to please you.

3. Set Goals for the organization and for them: An easy and fast way to get result in life and business is to set goals to help you achieve your vision. Thus, set short, medium and long term goals for the organization and for each department or staff.

Let your employees know their targets. Therefore, spell-out your expectation on measurable and understandable terms to them. Break major projects into smaller parts to make it easy to accomplish.

4. Train and re-train employees: The current information age requires that staffers should be trained and re-trained to enable them acquire requisite knowledge on their core task so that they can significantly contribute to the attainment of the overall objectives of the enterprise.

5. Assign employees jobs that will task their brain: Assigning staffers jobs that will task their brain will enable them to think deeply to provide solution to problems that will add value to the organization. So that it can attain its objectives.

6. Have faith in staffers to deliver: As the leader of the organization, when you delegate a task to a staff, exercise faith in his/her ability to deliver on the task. Indeed you should have faith that each member of the team has the ability to perform their task unless you didn’t conduct a proper recruitment Exercise.

It’s important to note that if you refuse to delegate task, you’re inadvertently making your workers lose faith in their abilities which might cause resentment that is not profitable to your business.

7. Provide career opportunities and remunerate staffers accordingly: Endeavour to provide an environment that will promote staffers prestige, recognition, pride, safety and good health, a sense of doing the right thing coupled with remuneration according to industry standard.

Compensation (such as promotion/bonuses) should be based upon the result rather than task performed. Always recognize and celebrate performers and do not hesitate to give credit when it’s merited.





Applications are invited from qualified candidates for admission into National Diploma (ND) Programme in Computer Science, (Part Time) School of Technology at Epe Campus for 2014/2015 academic session. The Programme will run for six (6) Semesters.


The entry requirement into the programme is as follows:

Five (5) credit passes at SSCE/NECO/NABTEB and not more than two (2) sittings in the following compulsory subjects: Physics, Mathematics and English Language plus any two of Statistics, Further Mathematics, Chemistry, Economics and Biology/Agriculture Science.


Applicants should visit the College website at Click on on-line application and complete the basic detail form.

Applicants should pay N10, 000.00 on-line using ATM card (Master Card, and Verve) by clicking on “pay now” (Please note that transaction charges is (N700.00). Kindly complete the on-line application form after payment. Click on “Submit” to conclude the application process. Applicants without an ATM card should approach any bank for a reloadable card and load the required amount to enable them pay on-line.

For details on available programmes of study and entry requirements visit Yabatech website at For further enquiries, applicants should contact the Deputy Registrar, Epe Campus.

Biekoroma C. Amapakabo

MasterCard-branded National eID Card Launched in Nigeria | Premium Time.


Nigerian Identity Management Commission (NIMC) will issue MasterCard-branded identity cards with electronic payments functionality to 13 million Nigerians. This initiative is the largest rollout of a biometric-based verification card with an electronic payment solution in the country and the broadest financial inclusion program in Africa. The eID card forms a key component of the Nigerian Identity Management System, deployed by NIMC as part of its mandate to create, maintain and operate the country’s first central National Identity Database and provide proof of identity to Nigerians 16 years and older. With 13 applications, including MasterCard’s prepaid payment technology and Cryptovision’s biometric identification technology, the eID card will provide millions of Nigerians – the majority of whom have never had access to a banking product – with the security, convenience and reliability of electronic payments. At a celebratory event held in Abuja, Goodluck Jonathan said: “I am happy that this important milestone of the rollout of the National Identity Management System has been realized today. I am impressed with the quality of the eID card and the work of the corporate partners that made it possible. I commend especially MasterCard, and Access Bank Plc, as well as the Commission [NIMC] for achieving a world-class product.” He said the card builds a window to a social security benefit system and therefore, it is a card every Nigerian should get. NIMC is working with several government agencies to integrate and harmonize all identity databases including the Driver’s License, Voter Registration, Health Insurance, Tax, SIM and the National Pension Commission (PENCOM) into a single, shared services platform. “The National eID program enables us to create an optimized common platform for Nigerian citizens to easily interact with the various government agencies and to transact electronically,” says Barr. Chris ‘E Onyemenam, Director General and CEO of NIMC. “There are many use cases for the card, including the potential to use it as an international travel document, which will have significant implications for border control in Nigeria and West Africa.” “In close collaboration with both the public and private sectors to achieve the full potential of this program, NIMC is focused on inclusive citizenship, more effective governance, and the creation of a cashless economy, all of which will stimulate economic growth, investment and trade,” he adds. Through the collaborative efforts of NIMC (the project lead), MasterCard (payments technology provider), Unified Payment Services Limited (payments processor), Cryptovision (Public Key Infrastructure and Trust Services Provider), and pilot issuing banks including Access Bank Plc, 13 million Nigerians will gain access to state-of-art financial services as part of the pilot program. “This is a memorable occasion for MasterCard as we witness the start of a financial inclusion program that is unprecedented in scale and scope,” says Daniel Monehin, Division President of Sub-Saharan Africa, MasterCard. “Combining an identity card with MasterCard’s prepaid payment capability creates a game changer as it breaks down one of the most significant barriers to financial inclusion – proof of identity – while simultaneously enabling Nigerians to access the global economy.” He said the broader economic impact of the card will be felt as the previously unbanked and under-banked are able to gain access to the mainstream economy, and the visibility of their assets allows them to build a financial history and establish credit-worthiness with financial institutions. Using the card as a payment tool, Nigerians can deposit funds, receive social benefits,save, or engage in many other financial transactions that are facilitated by electronic payments with the extra security assurance that biometric verification provides. They can also pay for goods and services and withdraw cash at millions of merchants and ATMS that accept MasterCard payment cards in Nigeria and in more than 210 countries and territories globally. MasterCard has unsurpassed merchant acceptance; no other brand is more widely accepted. The card also has the added safety and security benefits offered by the EMV Chip and Pin standard. Group Managing Director, Access Bank Plc Herbert Wigwe, said: “Access Bank is a supporter and promoter of innovative ideas that would improve the quality of lives of Nigerians. This initiative provides another opportunity to highlight our commitment to national development and nation building.” To receive the eID card, Nigerians aged 16 and above need to register at one of the hundreds of NIMC enrollment centers nationwide. The enrollment process involves the recording of an individual’s demographic data and biometric data (capture of 10 fingerprints, facial picture and Iris) to authenticate the cardholder and ensure that there are no duplicates on the system. Upon registration, NIMC issues each Nigerian with a unique National Identification Number (NIN), followed by the national eID card. Upon completion of the pilot program, NIMC plans to introduce more than 100 million cards to Nigeria’s 167 million citizens. “By supporting the Nigerian Government in the implementation of a world-class and innovative electronic payments program, we are helping them to reduce the costs of cash to the economy and society, improve efficiencies and prevent fraud and corruption. More importantly, we are opening up a world of financial inclusion to millions of Nigerians and improving lives,” says Monehin.

Death Toll From Ebola Outbreak Now 1229, Says WHO


The World Health Organisation (WHO) has said that 1,229 people have now died from Ebola outbreak across the West African countries of Guinea, Sierra Leone, Liberia, and Nigeria.
The increase takes into consideration happenings between 14th and 16th August 2014.
In those three days, a total of 113 new cases of Ebola virus disease (laboratory-confirmed, probable, and suspect cases) were recorded, while there were 84 deaths.
The global health body said the response of its officials and other partners to the Ebola Virus outbreak is continuing to grow in Guinea, Liberia, Nigeria, and Sierra Leone.
It added that to reduce the likelihood that those who are infected will carry the disease outside their communities, the governments have set up quarantine zones in areas of high transmission. These include severely-affected cities such as Gueckedou in Guinea, Kenema and Kailahun in Sierra Leone and Foya in Liberia.
“This [measure] prevents people living in these areas from moving to other parts of the country and potentially increasing EVD transmission. However, it also means that barriers to travel limit their access to food and other necessities”, it said.
“While preventing further transmission of EVD is crucial, it is essential that people in those zones have access to food, water, good sanitation and other basic supplies.
“WHO is working with the United Nations World Food Programme (WFP) to ensure people in the quarantine zones receive regular food aid and other non-medical supplies. WFP is now scaling up its programme to distribute food to the around 1 million people living in the quarantine zones in Guinea, Liberia, and Sierra Leone.
The health body also addressed the imposition of travel bans on the four West African countries, saying chances of contracting the virus via travels are “low”.
“WHO does not recommend any travel or trade restrictions be applied except in cases where individuals have been confirmed or are suspected of being infected with EVD or where individuals have had contact with cases of EVD,” it emphasised.


This is a “flying car” that perfectly makes use of existing infrastructure created for automobiles and planes, and opens doors to real door-to-door travel. In terms of automobile configuration, it fits to a standard parking space, its engine enables it to tank at any gas station, it is fully accustomed to road traffic and as a plane it could both take off and land at any airport in the world.









Spanish priest infected in Liberia dies

A Spanish missionary who contracted the Ebola virus while working in West Africa has died in hospital in Madrid.

More than 1,000 people have died in Liberia, Guinea, Sierra Leone and Nigeria since the outbreak was first reported in February.

Miguel Pajares, 75, was airlifted back to Spain from Liberia last week with a nun who tested negative for the virus.

For the past few days he had been treated with an untested, experimental drug, Zmapp.

A World Health Organization (WHO) panel in Geneva has meanwhile approved the ethics of using ZMapp.

According to the Reuters news agency, the panel said it was ethical to combat the Ebola outbreak by offering drugs or vaccines whose side-effects and efficacy had yet to be proven.

The priest was part of a Catholic order at St Joseph’s hospital in the Liberian capital, Monrovia.

The hospital has now been closed because of the outbreak.

A Congolese nun died there on Saturday, days after its director, Patrick Nshamdze, also died.

World Health Organization backs use of experimental Ebola drugs in West Africa

People infected in the West Africa Ebola outbreak can be offered untested drugs, the WHO said on Tuesday, but scarce supplies raise questions about who gets priority in the epidemic of the virus, which has no proven treatment.
Liberia said it planned to treat two infected doctors with an unproven Ebola medicine called ZMapp, the first Africans to receive the drug, while a Spanish priest, who the Health Ministry in Madrid said had also been given ZMapp, died.
The West Africa Ebola virus epidemic – the world’s largest and deadliest so far – has killed at least 1,013 people in Guinea, Liberia, Sierra Leone and Nigeria. The WHO has declared it an international health emergency and predicts the epidemic will continue for months.
There are no licensed treatments or vaccines for Ebola, but several biotech companies and research teams have been working on potential drugs. Some in West Africa took to social media to express their lack of hope of being offered those treatments.
“There was unanimous agreement among the experts that in the special circumstances of this Ebola outbreak it is ethical to offer unregistered interventions as potential treatments or prevention,” the WHO’s assistant director general Marie-Paule Kieny said after an ethics panel published its guidance.
The WHO-convened panel of medical ethicists said several potential drugs had passed the laboratory and animal study phases of development, and should now be fast-tracked into clinical trials as well as being made available for compassionate use.
The WHO ethics meeting was called after experimental Ebola drug ZMapp, made by U.S. biotech company Mapp Biopharmaceutical, was given to two American aid workers infected with Ebola in Liberia.
The two U.S. aid workers have shown some signs of improvements since being given the drug, and Kieny said she had heard reports that the treatment had had a swift and dramatic effect in these patients.
Only around 10 to 12 doses had been made of the experimental drug, according to the WHO. Liberia was preparing to treat the two Liberian doctors with ZMapp after U.S. authorities approved its export.
A 75-year-old priest in Spain, who the Health Ministry said was also being treated with ZMapp, died in hospital in Madrid on Tuesday. He contracted Ebola in Liberia while working for a non-governmental organisation.
Ben Neuman, a virologist at Britain’s University of Reading, said the WHO panel’s decision was welcome.
“The humanitarian case for treatment in a disease as deadly as Ebola is very clear cut. If I had Ebola, I would be looking for any treatment available, even if it was only at an experimental stage,” he said.
The epidemic in West Africa, one of the world’s poorest regions where crumbling healthcare systems are unable to cope, has also raised the issue of who should been given priority for any drug that might become available for compassionate use.
On Twitter, users in the region created the #GiveUsTheSerum hashtag to voice their frustration at the failure to provide experimental medicines to people on the continent.
The WHO’s ethics panel said it was likely the first tests of these drugs in humans would be conducted over the next two to four months, but cautioned that even after that and if the trials proved successful, supplies would be limited.
“It is … likely that the number of doses available for further study and/or deployment from end 2014 onwards will remain insufficient to meet demand,” the statement said.
Companies with possible treatments include Tekmira Pharmaceuticals, Biocryst Pharmaceuticals and Siga Technologies.
GlaxoSmithKline and U.S. scientists at the National Institute of Allergy and Infectious Diseases hope to start a clinical trial of an experimental Ebola vaccine as soon as next month, after promising test results in primates.
Another experimental vaccine from Johnson & Johnson’s Crucell unit should enter Phase I clinical trials in late 2015 or early 2016, while Profectus Biosciences is also working with U.S. scientists on another preclinical vaccine.
The WHO has said the epidemic will likely continue for months as the region’s healthcare systems struggle to cope and has appealed urgently for funding and emergency medical staff.
Ivory Coast, the economic powerhouse of French-speaking West Africa, on Monday banned air travellers from the three countries worst-hit by the Ebola outbreak and ordered its flagship carrier Air Cote d’Ivoire to cease flights to and from them.
Ivory Coast has not registered any cases but is seen as vulnerable given its shared borders with Guinea and Liberia.
Rwanda’s Health Ministry said the country’s first suspected case of Ebola, a German medical student who had spent time in Liberia, had tested negative.

US finally gives Ebola Cure to some countries in West African.

The Ebola drug given to two Americans and a Spanish priest has been sent to treat infected doctors in two West African countries, and the supply of the medicine is now gone, its manufacturer said.
Countries including Nigeria and Liberia had requested the drug, called ZMapp. Mapp Biopharmaceutical Inc., based in San Diego, said it has complied with every request for the drug that was authorized by legal and regulatory authorities. The drug was provided at no cost, according to Mapp.
“It is our understanding that all patients offered treatment, treated, or expected to be treated were or are highly capable of providing informed consent for the use of an experimental drug not yet evaluated for safety in animals or people,” the company said yesterday in a statement.

Mapp and its partners, Defyrus Inc. and a subsidiary of Reynolds American Inc., are working with the U.S. government to quickly increase production, the company said.
“Additional resources are being brought to bear on scaling up,” the company said. “The emergency use of an experimental medicine is a highly unusual situation.”
Providing a small amount of an experimental drug to West Africa won’t help control the outbreak, saidAnthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases. The focus needs to remain on basic public health and infection control measures, he said.

“How can a couple of doses control an outbreak with hundreds and hundreds of people?” Fauci said by phone. “You don’t control the epidemic with two or three doses.”
Mapp, in its statement, didn’t identify which countries had received the remaining doses. The company said those who requested the drug can reveal their acquisition or use of the experimental drug.
The Ebola outbreak has killed 1,013 of the 1,848 people infected in West Africa as of Aug. 9, theWorld Health Organization said in a statement on–update-11-august-2014.html. While other diseases are much more common and deadly, there is no cure for Ebola and it has moved quickly between countries, putting the global health community in high alert. Widespread malaria, which killed more than 600,000 people last year, is preventable and curable, according to the WHO.
A panel of ethicists convened by the WHO began meeting yesterday to weigh the use of experimental drugs that have shown early promise against Ebola. The panel is considering whether the drugs, which haven’t been widely tested for safety, should be used in an outbreak where 40 percent of infected people survive and, if so, who should get them from what may be a limited supply.

“This is the first effort to have a long-overdue, transparent, public discussion about how to distribute life-saving medicines in an emergency,” said Arthur Caplan, director of the division of medical ethics at NYU Langone Medical Center, in a telephone interview. “A ton of attention is going to follow this panel.”
The urgency to access the treatments has increased as health officials in the U.S., Canada andHong Kong have isolated and tested travelers with Ebola-like symptoms, before ruling out the disease. Medical experts have said the deadly virus could travel outside of West Africa.
U.S. regulators last week said a treatment by Tekmira Pharmaceuticals Corp. could be tested in infected patients, while Mapp’s drug has already been used to treat two American aid workers Kent Brantly and Nancy Writebol, who were infected in Liberia. The pair were flown to Emory University Hospital in Atlanta, where relatives and supporters have said they are improving, though it remains unclear if or how much the drug helped.

Sierra Leone is awaiting the outcome of the WHO panel before pursuing ZMapp, and the country has approached Tekmira about getting access to its product, Sierra Leone Chief Medical Officer Brima Kargbo said in a telephone interview.
Other companies developing treatments or vaccines for the deadly disease include Fujifilm Holdings Corp., BioCryst Pharmaceuticals Inc., and Sarepta Therapeutics Inc.
Ebola is normally treated by keeping patients hydrated, replacing lost blood and using antibiotics to fight off opportunistic infections. The hope is that a patient’s immune system will eventually fight off the virus’s aggressive attack.
Erica Ollmann Saphire, a molecular biologist who works on Ebola treatments with the Scripps Research Institute, said experimental drugs should go first to medical staff and aid workers.

“They are taking care of others at great risk to themselves,” Saphire said in an e-mail. “If the treatments help them survive, they could return to care for other patients, so the effect of the treatment would be compounded. Further, the health-care workers that survive may even become immune, and much better able to help in the future.”
The limited supply of the drug could create problems, Caplan said, questioning whether a patient’s condition should matter in determining who gets treated.
“The more recently you’ve been infected, the more likely you’ll respond better than if you’re 20 days out,” he said. “How about young versus old? Do we care if you’re 10 or if you’re 80?” The WHO plans a news conference at 2 p.m. Geneva time today to discuss the meeting of the ethics panel.
Researchers say the outbreak probably began in December with a 2-year-old child in Guinea, and the disease has raced through Guinea, Liberia and Sierra Leone, and recently entered Nigeria, which has recorded two Ebola-related deaths as of Aug. 9.